Padua, Italy

Enzo Bronte


 

Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • Rozzano, IT (2013)
  • Padua, IT (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Enzo Bronte: Innovator in Antitumor Compounds

Introduction

Enzo Bronte is a notable inventor based in Padua, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antitumor activity. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Bronte's latest patents include "Water soluble furoxan derivatives having antitumor activity." This invention provides water-soluble compounds with a furoxan structure that can inhibit metabolic pathways involved in tumor development. The compounds are also described for their use as medicaments in tumor therapy and as adjuvants in immunotherapy protocols against neoplasms. Another significant patent is "Nitric oxide furoxan derivative compounds endowed with antitumoral activity." This invention relates to nitric oxide furoxan derivative compounds that have shown effectiveness in treating tumors and may serve as adjuvants in cancer immunotherapy.

Career Highlights

Throughout his career, Enzo Bronte has worked with esteemed organizations such as Humanitas Mirasole S.p.a. and Istituto Oncologico Veneto Irccs. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Bronte has collaborated with notable colleagues, including Antonella Viola and Marco Crosetti. These partnerships have enriched his research and expanded the impact of his inventions in the medical field.

Conclusion

Enzo Bronte's work in developing antitumor compounds showcases his dedication to advancing cancer treatment. His innovative patents and collaborations highlight his significant contributions to medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…